# A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

> **NCT07455825** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 64 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD5004

## Key facts

- **NCT ID:** NCT07455825
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-09
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455825, "A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07455825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*